Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk
- PMID: 29042060
- DOI: 10.1016/j.healthpol.2017.09.022
Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk
Abstract
Objectives: To compare the determinants of initial statin prescribing between New Zealand and Australia. New Zealand has a system-wide absolute risk-based approach to primary care cardiovascular disease (CVD) management, while Australia has multiple guidelines.
Method: Classification and Regression Tree (CART) analysis of two observational studies of primary care CVD management from New Zealand (PREDICT-CVD) and Australia (AusHeart). Over 80% of eligible New Zealanders have been screened for CVD risk. PREDICT-CVD is used by approximately one-third of New Zealand GPs to perform web-based CVD risk assessment in routine practice, with the sample consisting of 126,519 individuals risk assessed between 1 January 2007 and 30 June 2014. AusHeart is a cluster-stratified survey of primary care CVD management that enrolled 534 GPs from across Australia, who in turn recruited 1381 patients between 1 April and 30 June 2008. Eligibility was restricted to 55-74year old patients without prior CVD.
Results: The CART analyses demonstrated that New Zealand GPs prescribe statins primarily on the basis of absolute risk, while their Australian counterparts are influenced by a variety of individual risk factors, including total cholesterol, LDL cholesterol and diabetes.
Conclusions: Countries seeking to improve their management of CVD should consider adopting a 'whole of system' absolute risk-based approach with clear guidelines that are consistent with drug reimbursement rules; and include computerized decision-support tools that aid decision-making and allow monitoring of outcomes and continual improvement of practice.
Keywords: CART; Cardiovascular disease; Funding of health care; Prescribing.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.N Z Med J. 2017 Oct 6;130(1463):28-38. N Z Med J. 2017. PMID: 28981492
-
Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.Pharmacoeconomics. 2016 Feb;34(2):195-205. doi: 10.1007/s40273-015-0342-3. Pharmacoeconomics. 2016. PMID: 26578402
-
Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study).Med J Aust. 2010 Mar 1;192(5):254-9. doi: 10.5694/j.1326-5377.2010.tb03502.x. Med J Aust. 2010. PMID: 20201758
-
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9. Nutr Metab Cardiovasc Dis. 2013. PMID: 23932901 Review.
-
Intensive statin therapy for Indians: Part-I. Benefits.Indian Heart J. 2011 May-Jun;63(3):211-27. Indian Heart J. 2011. PMID: 22734339 Review.
Cited by
-
Factors predicting statin prescribing for primary prevention: a historical cohort study.Br J Gen Pract. 2021 Feb 25;71(704):e219-e225. doi: 10.3399/bjgp20X714065. Print 2021. Br J Gen Pract. 2021. PMID: 33558331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous